‘Exciting Time’ for Pancreas Cancer Treatment as New Device Offers Hope for Improved Lifespan, Quality of Life
A Nebraska Medicine oncologist discusses a clinical trial using a catheter-based approach designed to deliver chemotherapy near pancreatic tumors.
RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million
RenovoRx today announced its financial results for the third quarter ended September 30, 2026 and provided shareholders with a business update highlighting continued commercial momentum and clinical progress.